~~<i id='A1B431EC9E'><strike id='A1B431EC9E'><tt id='A1B431EC9E'><pre id='A1B431EC9E'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

author：fashion 2025-10-01 17:34:47 - browse：557

Martin Shkreli Securities Fraud Trial — Kevin Hagen/Getty Images

Is this the end of the line for the “pharma bro” with the perpetual smirk?

Martin Skhreli was found guilty on Friday of three counts of fraud after a five-week trial in federal court in Brooklyn, N.Y. He faces a prison sentence that could stretch years.

“This was a witch hunt of epic proportions,” Shkreli said outside court after the verdict, the Washington Post reported. “They may have found some broomsticks.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Trans patients at the end of life deserve respect and dignity

hotspot

leisure time

hotspot

leisure time

explore

Wikipedia

DrugmakersalreadybetbigonmRNAforcancer.NowPresidentBidenisgoingin,too?AnnaMoneymaker/GettyImagesWASH

WSS

With Wegovy coverage, Medicare patients may face high costs

Readout Newsletter: Illumina, CRISPR, Regeneron

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

Intellia plays down concerns on accidental germline transmission

Roche's accidental data boosts hopes for anti

Biotech investment managers search for lucrative opportunities

focus

focus

hotspot

Jerome Adams on the need for new antivirals for Covid

With Wegovy coverage, Medicare patients may face high costs

After affirmative action ruling, medical educators look to 'holistic review'

Intellia plays down concerns on accidental germline transmission

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Cancer, immunology, HIV research ensnared in fetal tissue politics

State Dept. review finds Biden bears some blame for Afghanistan failures

What Kate Middleton's cancer revelation might teach the world

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Chinese researcher claims birth of first gene

leisure time

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Diabetes management: Digital health tools fall short, study says

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

Health officials lay out plans to cope with respiratory virus season

Yancopoulos of Regeneron works to expand Dupixent success

Yancopoulos of Regeneron works to expand Dupixent success

hotspot

leisure time

explore

Wikipedia